Back to search
Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This pilot phase I trial studies the side effects of durvalumab and tremelimumab in treating patients with muscle-invasive, high-risk urothelial cancer that can…
This phase II trial studies how well pemetrexed and avelumab work in treating patients with MTAP-deficient urothelial cancer that has spread to other places in…
This phase II trial studies the side effects of durvalumab and chemotherapy before surgery in treating patients with variant histology bladder cancer. Immunothe…